Òscar Reig

HIF-2 Complex Dissociation, Target Inhibition, and Acquired Resistance with PT2385, a First-in-Class HIF-2 Inhibitor, in Patients with Clear Cell Renal Cell Carcinoma

Kevin D. Courtney, Yuanqing Ma, Alberto Diaz de Leon et al. · Clinical Cancer Research · 2019 · 184 citations · Full text

Medicine, Oncology, Pharmacology +16

Epithelial-to-Mesenchymal Transition Mediates Docetaxel Resistance and High Risk of Relapse in Prostate Cancer

Mercedes Marín‐Aguilera, Jordi Codony‐Servat, Òscar Reig et al. · Molecular Cancer Therapeutics · 2014 · 148 citations · Full text

Medicine, Oncology, Urology +17

TMPRSS2-ERG in Blood and Docetaxel Resistance in Metastatic Castration-resistant Prostate Cancer

Òscar Reig, Mercedes Marín‐Aguilera, Gemma Carrera et al. · European Urology · 2016 · 101 citations

Medicine, Oncology, Urology +14

Association between PD1 mRNA and response to anti-PD1 monotherapy across multiple cancer types

Laia Paré, Tomás Pascual, Elia Seguí et al. · Annals of Oncology · 2018 · 99 citations · Full text

Life Sciences, Immunology, Oncology +17

Pancreatic tropism of metastatic renal cell carcinoma

Nirmish Singla, Zhiqun Xie, Ze Zhang et al. · JCI Insight · 2020 · 88 citations · Full text

Medicine, Cancer Biology, Oncology +17